The Problem With Health Care Price Transparency: We Don’t Have Cost Transparency

A patient prepares to undergo a MRI at the Oscar Lambret Center in Lille, northern France, a regional medical unit specialised in cancer's treatment, on Feb. 6, 2013. Philippe Huguen/AFP/Getty Images

Commentary

$2.4 million. $1.5 million. $2.28 million. These are the amounts of money the health system where I work, teach, and receive health care spent purchasing a PET scanner, a CT scanner, and a three-month supply of pembrolizumab, a drug that treats a variety of solid-organ cancers.